167 related articles for article (PubMed ID: 23370437)
1. Preparation, characterization, and in vivo evaluation of doxorubicin loaded BSA nanoparticles with folic acid modified dextran surface.
Hao H; Ma Q; Huang C; He F; Yao P
Int J Pharm; 2013 Feb; 444(1-2):77-84. PubMed ID: 23370437
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles with dextran/chitosan shell and BSA/chitosan core--doxorubicin loading and delivery.
Qi J; Yao P; He F; Yu C; Huang C
Int J Pharm; 2010 Jun; 393(1-2):176-84. PubMed ID: 20381598
[TBL] [Abstract][Full Text] [Related]
3. Green preparation process, characterization and antitumor effects of doxorubicin-BSA-dextran nanoparticles.
Deng W; Li J; Yao P; He F; Huang C
Macromol Biosci; 2010 Oct; 10(10):1224-34. PubMed ID: 20602420
[TBL] [Abstract][Full Text] [Related]
4. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.
Lee KD; Choi SH; Kim DH; Lee HY; Choi KC
Arch Pharm Res; 2014 Dec; 37(12):1546-53. PubMed ID: 25280540
[TBL] [Abstract][Full Text] [Related]
5. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
8. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
10. Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo.
Yang R; An Y; Miao F; Li M; Liu P; Tang Q
Int J Nanomedicine; 2014; 9():4231-43. PubMed ID: 25228802
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
[TBL] [Abstract][Full Text] [Related]
12. Size- and pathotropism-driven targeting and washout-resistant effects of boronic acid-rich protein nanoparticles for liver cancer regression.
Wang J; Zhang Z; Wang X; Wu W; Jiang X
J Control Release; 2013 May; 168(1):1-9. PubMed ID: 23459020
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin and Fe
Hao H; Ma Q; He F; Yao P
J Mater Chem B; 2014 Dec; 2(45):7978-7987. PubMed ID: 32262088
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.
Wang X; Zhen X; Wang J; Zhang J; Wu W; Jiang X
Biomaterials; 2013 Jun; 34(19):4667-79. PubMed ID: 23537667
[TBL] [Abstract][Full Text] [Related]
15. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
[TBL] [Abstract][Full Text] [Related]
16. Heat-treated emulsions with cross-linking bovine serum albumin interfacial films and different dextran surfaces: effect of paclitaxel delivery.
Qi J; Huang C; He F; Yao P
J Pharm Sci; 2013 Apr; 102(4):1307-17. PubMed ID: 23389967
[TBL] [Abstract][Full Text] [Related]
17. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery.
Du C; Deng D; Shan L; Wan S; Cao J; Tian J; Achilefu S; Gu Y
Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705
[TBL] [Abstract][Full Text] [Related]
18. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
[TBL] [Abstract][Full Text] [Related]
19. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]